Count Roy model with finite mixtures
具有有限混合结构的计数 Roy 模型AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确建立 Roy 选择模型,并借助工具变量估计保险对处方药利用的处理效应。
具有有限混合结构的计数 Roy 模型AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Summary This paper develops the Finite Mixture Roy model for count variables and uses this semiparametric model to analyze the effect of supplemental Medigap private insurance on the demand for prescription drugs for the U.S. elderly unemployed Medicare population. The model is an extension of the Count Roy model, which produces unrealistic treatment effects when observed count patterns are consistent with finite mixtures. To estimate the numbers of components in the mixtures for individuals with and without Medigap, this paper adopts the random permutation sampler. The considered application motivates two additional features of the model. Specifically, the smoothly mixing regression approach is utilized to model the probabilities of the components, and a continuous instrumental variable is allowed to enter the treatment equation nonparametrically. Strong evidence is found that there are two components both in the treated and untreated states. These lower and higher utilization components are interpreted as relatively healthy and unhealthy groups. The estimated treatment effects show that Medigap insurance provides incentives to increase prescription drug utilization by 2%. The results are consistent with adverse selection.